Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 

Click here to go back to your search results.

Non-Hodgkin's Lymphoma treatment details. Chemotherapy. University of Tokyo, Tokyo, Japan



Survival: 11.0 months
   
Toxicity Grade: 4
   
Treatments: Chemotherapy
   
Drugs:
Country: Japan
   
City/State/Province: Tokyo
   
Hospital: University of Tokyo
   
Journal: Link
   
Date: 6/2015

Description:
Patients:
This study involved 22 peripheral T cell lymphoma patients who had received prior treatment. The median patient age was 59 years and 64% were male.

Treatment:
Patients received the chemotherapy regimen called mESHAP, which consisted of etoposide, methylprednisolone, high-dose cytarabine, and carboplatin.

Toxicities:
The most severe toxicities were of grade 4 and included leukopenia, anemia, and thrombocytopenia.

Results:
The median overall survival was 11.0 months.

Support:
Some of the study authors have received past funding from various pharmaceutical companies.

Correspondence: Dr. Mineo Kurokawa; email: kurokawa-tky@umin.ac.jp

E-mail to a Friend Email Physician More Information